Trial Profile
A phase three double blind placebo controlled trial of long-term therapy of herpes simplex encephalitis: an evaluation of valacyclovir [valaciclovir]
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Jul 2005
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex encephalitis
- Focus Therapeutic Use
- 20 Jul 2005 New trial record.